Department of Medical Microbiology, Pathology Building, University of Pretoria, Prinshof Campus, Corner of Steve Biko Road and Dr Savage Road, Pretoria, 0084, South Africa.
Tshwane Academic Division, National Health Laboratory Service, Corner of Steve Biko Road and Dr Savage Road, Pretoria, 0084, South Africa.
BMC Infect Dis. 2019 Sep 14;19(1):806. doi: 10.1186/s12879-019-4391-7.
Non-typhoidal salmonellae (NTS) have been associated with invasive disease, notably meningitis, in immunocompromised individuals. Infections of this nature carry high rates of morbidity and mortality. Colistin resistance in salmonellae is a rare finding, more so in an invasive isolate such as cerebrospinal fluid (CSF). Colistin resistance has important infection control implications and failure to manage this phenomenon may lead to the loss of our last line of defence against multi-drug resistant Gram-negative organisms. To our knowledge, this is the first reported clinical case of colistin-resistant Salmonella Enteritidis meningitis in South Africa.
We report a case of a young male patient with advanced human immunodeficiency virus (HIV) infection who presented to hospital with symptoms of meningitis. Cerebrospinal fluid (CSF) cultured a Salmonella Enteritidis strain. Antimicrobial susceptibility testing (AST) of the isolate, revealed the strain to be colistin resistant. Despite early and aggressive antimicrobial therapy, the patient succumbed to the illness after a short stay in hospital. Subsequent genomic analysis of the isolate showed no presence of the mcr genes or resistance-conferring mutations in phoPQ, pmrAB, pmrHFIJKLME/arnBCADTEF, mgrB, and acrAB genes, suggesting the presence of a novel colistin resistance mechanism.
Invasive non-typhoidal salmonellae infection should be suspected in patients with advanced immunosuppression who present with clinical features of meningitis. Despite early and appropriate empiric therapy, these infections are commonly associated with adverse outcomes to the patient. Combination therapy with two active anti-Salmonella agents may be a consideration in the future to overcome the high mortality associated with NTS meningitis. Colistin resistance in clinical Salmonella isolates, although a rare finding at present, has significant public health and infection control implications. The causative mechanism of resistance should be sought in all cases.
非伤寒沙门氏菌(NTS)与免疫功能低下个体的侵袭性疾病有关,尤其是脑膜炎。此类感染的发病率和死亡率都很高。沙门氏菌对黏菌素的耐药性是一种罕见的发现,在侵袭性分离株如脑脊液(CSF)中更为罕见。黏菌素耐药性对感染控制具有重要意义,如果不能对此进行管理,可能会导致我们失去对抗多药耐药革兰氏阴性菌的最后一道防线。据我们所知,这是南非首例报告的黏菌素耐药肠炎沙门氏菌脑膜炎的临床病例。
我们报告了一例年轻男性艾滋病病毒(HIV)感染者,因脑膜炎症状就诊于医院。脑脊液(CSF)培养出肠炎沙门氏菌。分离株的抗菌药物敏感性测试(AST)显示该菌株对黏菌素耐药。尽管早期和积极的抗菌治疗,但患者在住院后不久仍因疾病去世。对分离株的后续基因组分析显示,mcr 基因或 phoPQ、pmrAB、pmrHFIJKLME/arnBCADTEF、mgrB 和 acrAB 基因中的耐药基因均不存在,提示存在新的黏菌素耐药机制。
对于出现脑膜炎临床特征的晚期免疫抑制患者,应怀疑侵袭性非伤寒沙门氏菌感染。尽管早期和适当的经验性治疗,但这些感染通常与患者的不良预后相关。未来可能需要联合使用两种有效的抗沙门氏菌药物进行治疗,以克服 NTS 脑膜炎相关的高死亡率。目前,临床沙门氏菌分离株对黏菌素的耐药性虽然罕见,但对公共卫生和感染控制具有重要意义。应在所有情况下寻找耐药的原因。